CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR In 2022, Lonza …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Roche: Lower Guidance In 2023, But Positive Trajectory - February 2, 2023
- Roche’s (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal - February 2, 2023
- What to know about congestive heart failure and coughing - February 2, 2023